phenoxybenzamine has been researched along with Migraine Disorders in 3 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The ability of migraine patients to oxidatively deaminate phenylethylamine is reduced at the time of their attacks." | 1.26 | Factors influencing the response of the cerebral circulation to phenylethylamine. ( Harper, AM; McCulloch, J, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCulloch, J | 1 |
| Harper, AM | 1 |
| Berde, B | 1 |
| Hessov, I | 1 |
| Kromann-Andersen, C | 1 |
| Madsen, B | 1 |
3 other studies available for phenoxybenzamine and Migraine Disorders
| Article | Year |
|---|---|
Factors influencing the response of the cerebral circulation to phenylethylamine.
Topics: Animals; Blood-Brain Barrier; Cerebrovascular Circulation; Haplorhini; Migraine Disorders; Monoamine | 1979 |
Some new vascular and biochemical aspects of the mechanism of action of ergot compounds.
Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Ergoloid Mesylates; Ergot Alkaloids; Ergotamine; Migrai | 1972 |
Peripheral arterial insufficiency during ergotamine treatment. Course of disease, angiographical findings, and treatment by phenoxybenzamine.
Topics: Adult; Arm; Arterial Occlusive Diseases; Ergotamine; Female; Humans; Leg; Migraine Disorders; Phenox | 1972 |